Literature DB >> 17335815

Expression of the CUB domain containing protein 1 (CDCP1) gene in colorectal tumour cells.

Sara E Perry1, Philip Robinson, Alan Melcher, Philip Quirke, Hans-Jörg Bühring, Graham P Cook, G Eric Blair.   

Abstract

Expression of CUB domain containing protein 1 (CDCP1) is upregulated in carcinoma cells. We quantitated CDCP1 gene expression in matched normal colon and tumour tissue and compared the level of expression to other genes upregulated in colorectal tumourigenesis. Furthermore, we show that the CDCP1 gene generates two transcripts which are co-expressed in normal and matched tumour tissue as well as in the majority of cell lines analysed. However, intracellular localisation studies revealed that only one of these transcripts encodes a protein that is localised to the cell surface.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17335815     DOI: 10.1016/j.febslet.2007.02.025

Source DB:  PubMed          Journal:  FEBS Lett        ISSN: 0014-5793            Impact factor:   4.124


  22 in total

1.  The transmembrane src substrate Trask is an epithelial protein that signals during anchorage deprivation.

Authors:  Danislav S Spassov; Frederick L Baehner; Ching Hang Wong; Stephen McDonough; Mark M Moasser
Journal:  Am J Pathol       Date:  2009-04-06       Impact factor: 4.307

2.  CDCP1 drives triple-negative breast cancer metastasis through reduction of lipid-droplet abundance and stimulation of fatty acid oxidation.

Authors:  Heather J Wright; Jue Hou; Binzhi Xu; Marvin Cortez; Eric O Potma; Bruce J Tromberg; Olga V Razorenova
Journal:  Proc Natl Acad Sci U S A       Date:  2017-07-24       Impact factor: 11.205

3.  CUB-domain-containing protein 1 (CDCP1) activates Src to promote melanoma metastasis.

Authors:  Hui Liu; Shao-En Ong; Kwabena Badu-Nkansah; Jeffrey Schindler; Forest M White; Richard O Hynes
Journal:  Proc Natl Acad Sci U S A       Date:  2011-01-10       Impact factor: 11.205

4.  RNA sequencing to study gene expression and SNP variations associated with growth in zebrafish fed a plant protein-based diet.

Authors:  Pilar E Ulloa; Gonzalo Rincón; Alma Islas-Trejo; Cristian Araneda; Patricia Iturra; Roberto Neira; Juan F Medrano
Journal:  Mar Biotechnol (NY)       Date:  2015-02-22       Impact factor: 3.619

5.  The SRC-associated protein CUB Domain-Containing Protein-1 regulates adhesion and motility.

Authors:  C H Benes; G Poulogiannis; L C Cantley; S P Soltoff
Journal:  Oncogene       Date:  2011-07-04       Impact factor: 9.867

6.  Identification of CDCP1 as a hypoxia-inducible factor 2α (HIF-2α) target gene that is associated with survival in clear cell renal cell carcinoma patients.

Authors:  Brooke M Emerling; Cyril H Benes; George Poulogiannis; Eric L Bell; Kevin Courtney; Hui Liu; Rayman Choo-Wing; Gary Bellinger; Kazumi S Tsukazawa; Victoria Brown; Sabina Signoretti; Stephen P Soltoff; Lewis C Cantley
Journal:  Proc Natl Acad Sci U S A       Date:  2013-02-01       Impact factor: 11.205

7.  In vivo cleaved CDCP1 promotes early tumor dissemination via complexing with activated β1 integrin and induction of FAK/PI3K/Akt motility signaling.

Authors:  B Casar; I Rimann; H Kato; S J Shattil; J P Quigley; E I Deryugina
Journal:  Oncogene       Date:  2012-12-03       Impact factor: 9.867

8.  HIF-2α regulates CDCP1 to promote PKCδ-mediated migration in hepatocellular carcinoma.

Authors:  Manqing Cao; Junrong Gao; Hongyuan Zhou; Jiafei Huang; Abin You; Zhigui Guo; Feng Fang; Wei Zhang; Tianqiang Song; Ti Zhang
Journal:  Tumour Biol       Date:  2015-08-26

9.  Phosphorylation of the SRC epithelial substrate Trask is tightly regulated in normal epithelia but widespread in many human epithelial cancers.

Authors:  Ching Hang Wong; Frederick L Baehner; Danislav S Spassov; Deepika Ahuja; Donghui Wang; Byron Hann; Jimmy Blair; Kevan Shokat; Alana L Welm; Mark M Moasser
Journal:  Clin Cancer Res       Date:  2009-03-24       Impact factor: 12.531

10.  Functional role of cell surface CUB domain-containing protein 1 in tumor cell dissemination.

Authors:  Elena I Deryugina; Erin M Conn; Andreas Wortmann; Juneth J Partridge; Tatyana A Kupriyanova; Veronica C Ardi; John D Hooper; James P Quigley
Journal:  Mol Cancer Res       Date:  2009-08-11       Impact factor: 5.852

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.